and the human genome.
If my email is any indication, investors are truly obsessed with
HOLDRs are a great way to invest in hot areas of the market. They're straightforward, cheap and easy to buy and trade. You can pick up shares from any broker.
Merrill launched the first of these
exchange-traded portfolios, Internet HOLDRs
, last September.
Now there are six others, covering
, or business-to-business,
All of these baskets start off with 20 stocks, trade on the
American Stock Exchange
and carry the same investment restrictions. You can buy HOLDRs only in round lots, or increments of 100 shares. So it will cost you anywhere from around $7,900 (pharmaceutical) to around $23,000 (biotech) to get into HOLDRs.
At launch, the holdings of each portfolio are weighted according to market capitalization, with a 20% ceiling on any one stock. The weightings change constantly as each stock's price fluctuates.
Alas, you'll have one difficult time locating the weightings -- or the holdings -- of HOLDRs on the Internet.
Maddeningly, you won't find that information on Merrill's
Web site. And searching for the information in the
Edgar database is frustrating, and you won't find recent weightings there.
Bank of New York
, the trustee for the HOLDRs products, has portfolio holdings, but not current weightings, on its
Well, you can now find the holdings, and the weightings as of Wednesday, right here on
Say thank you.
Dear Dagen aims to provide general fund information. Under no circumstances does the information in this column represent a recommendation to buy or sell funds or other securities.